LMR Partners’s CONMED CNMD Stock Holding History

LMR Partners’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-10,520	Closed	-$1.01M	–	1225
2022 Q2	$1.01M	Buy	+10,520	New	+$1.26M	0.02%	728
2018 Q3	–	Sell	-4,529	Closed	-$332K	–	386
2018 Q2	$332K	Buy	+4,529	New	+$308K	0.02%	333

Other funds holding CNMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

LMR Partners's CNMD Position: Q3 2022 in Review

LMR Partners sold out of CONMED (CNMD) in Q3 2022, closing a stake of 10,520 shares — an estimated $1.01M sold.

LMR Partners first reported a position in CNMD in Q2 2018 and held it in 2 quarters. The position peaked at $1.01M in Q2 2022. 252 funds tracked by Wall St. Rank hold CNMD as of Q3 2022.

LMR Partners reported no remaining CONMED position as of Q3 2022 after selling out during the quarter.
LMR Partners sold 10,520 CONMED shares in Q3 2022, an estimated $1.01M.
LMR Partners first reported a position in CONMED in Q2 2018 and held it in 2 quarters.
LMR Partners's CONMED position peaked at $1.01M in Q2 2022.
252 funds tracked by Wall St. Rank held CONMED as of Q3 2022.

Based on LMR Partners's 13F filing for Q3 2022, filed 14 Nov 2022.